Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

India · Delayed Price · Currency is INR

33.30

-0.87 (-2.55%)

Feb 19, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharma Division	266.60M	278.68M	-	190.05M	271.51M
Pharma Division Growth	-4.33%	-	-	-30.00%	-
Chemical Division	67.42M	121.67M	-	33.77M	93.99M
Chemical Division Growth	-44.59%	-	-	-64.07%	-
Total	334.02M	400.35M	-	223.82M	365.50M
Total Growth	-16.57%	-	-	-38.76%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	335.82M	404.09M	300.35M	223.82M	358.10M
India Growth	-16.89%	34.54%	34.19%	-37.50%	20.30%
Total	335.82M	404.09M	300.35M	223.82M	358.10M
Total Growth	-16.89%	34.54%	34.19%	-37.50%	20.30%

Source: S&P Global Market Intelligence.